Morgan Stanley Trans Medics Group, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Morgan Stanley holds 454,438 shares of TMDX stock, worth $32.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

454,438

Previous 522,905 13.09%

Holding current value

$32.7 Million

Previous $82.1 Million 65.49%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$59.28 - $144.9 $4.06 Million - $9.92 Million	-68,467 Reduced 13.09%	454,438 $28.3 Million
Q3 2024 Nov 14, 2024	BUY	$135.68 - $176.11 $1.53 Million - $1.98 Million	11,269 Added 2.2%	522,905 $82.1 Million
Q2 2024 Oct 17, 2024	BUY	$72.62 - $150.62 $4.85 Million - $10.1 Million	66,729 Added 15.0%	511,636 $77.1 Million
Q2 2024 Aug 14, 2024	BUY	$72.62 - $150.62 $4.85 Million - $10.1 Million	66,729 Added 15.0%	511,636 $77.1 Million
Q1 2024 Oct 17, 2024	SELL	$70.86 - $89.93 $4.73 Million - $6 Million	-66,729 Reduced 13.04%	444,907 $32.9 Million
Q1 2024 Aug 16, 2024	SELL	$70.86 - $89.93 $2.48 Million - $3.14 Million	-34,939 Reduced 7.28%	444,907 $32.9 Million
Q1 2024 May 15, 2024	SELL	$70.86 - $89.93 $2.48 Million - $3.14 Million	-34,939 Reduced 7.28%	444,907 $32.9 Million
Q4 2023 Aug 16, 2024	SELL	$36.74 - $81.08 $1.17 Million - $2.58 Million	-31,790 Reduced 6.21%	479,846 $37.9 Million
Q4 2023 Feb 13, 2024	SELL	$36.74 - $81.08 $1.25 Million - $2.75 Million	-33,951 Reduced 6.61%	479,846 $37.9 Million
Q3 2023 Nov 15, 2023	SELL	$53.47 - $96.07 $4.15 Million - $7.45 Million	-77,547 Reduced 13.11%	513,797 $28.1 Million
Q2 2023 Aug 14, 2023	BUY	$66.23 - $88.73 $4 Million - $5.36 Million	60,459 Added 11.39%	591,344 $49.7 Million
Q1 2023 May 15, 2023	BUY	$53.63 - $82.33 $10.6 Million - $16.3 Million	197,998 Added 59.48%	530,885 $40.2 Million
Q4 2022 Feb 14, 2023	SELL	$39.08 - $64.29 $1.39 Million - $2.29 Million	-35,689 Reduced 9.68%	332,887 $20.5 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $9.7 Million - $17.1 Million	307,301 Added 501.51%	368,576 $15.4 Million
Q2 2022 Oct 27, 2022	BUY	$20.56 - $32.15 $734,588 - $1.15 Million	35,729 Added 139.86%	61,275 $1.93 Million
Q2 2022 Aug 15, 2022	BUY	$20.56 - $32.15 $734,588 - $1.15 Million	35,729 Added 139.86%	61,275 $1.93 Million
Q1 2022 Oct 27, 2022	SELL	$12.58 - $26.94 $449,470 - $962,539	-35,729 Reduced 58.31%	25,546 $688,000
Q1 2022 May 13, 2022	SELL	$12.58 - $26.94 $350,604 - $750,817	-27,870 Reduced 52.18%	25,546 $688,000
Q4 2021 Feb 14, 2022	SELL	$19.16 - $32.68 $1.39 Million - $2.38 Million	-72,742 Reduced 57.66%	53,416 $1.02 Million
Q3 2021 Nov 15, 2021	BUY	$25.92 - $34.51 $3.27 Million - $4.35 Million	126,158 New	126,158 $4.18 Million

Others Institutions Holding TMDX

# of Institutions

345

Shares Held

30.5M

Call Options Held

671K

Put Options Held

858K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.29B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account